NYS DOH: Prioritization of Monoclonal Antibodies and Oral Antivirals for the Treatment of COVID-19

NYS DOH: Prioritization of Monoclonal Antibodies and Oral Antivirals for the Treatment of COVID-19

January 4th, 2022 | Clinical ResourcesCOVID-19Covid Pharmacy
Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download PDF [180.15 KB]